A simple HPLC-UV method for the determination of lacosamide in human plasma

Bioanalysis

Volumn 3, Issue 22, 2011, Pages 2515-2522

  Kestelyn, C ^a   Lastelle, M ^a   Higuet, N ^a   Dell'Aiera, S ^a   Staelens, L ^a   Boulanger, P ^a   Boekens, H ^a   Smith, S ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; HARKOSERIDE; METHANOL;

ACCURACY; ARTICLE; CALIBRATION; CENTRIFUGATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; MALE; PH MEASUREMENT; PRECIPITATION; PROCESS DEVELOPMENT; RELIABILITY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SUPERNATANT; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ACETAMIDES; ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; HUMANS; MALE; SPECTROPHOTOMETRY, ULTRAVIOLET; TANDEM MASS SPECTROMETRY;

EID: 82455162826     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.261     Document Type: Article

References (11)

1. Beydoun A, D'Souza J, Hebert D, Doty P. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev. Neurother. 9(1), 33-42 (2009).
2. Sattler A, Schaefer M, May TW, Rambeck B, Brandt C. Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions - first clinical experience. Epilepsy Res. 95(3), 207-212 (2011).
3. Greenaway C, Ratnaraj N, Sander JW, Patsalos PN. A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy. Ther. Drug Monit. 32(4), 448-452 (2010).
4. Greenaway C, Ratnaraj N, Sander JW, Patsalos PN. Saliva and serum lacosamide concentrations in patients with epilepsy. Epilepsia 52(2), 258-263 (2011).
5. Kim SJ, Koo TS, Ha DJ et al. Liquid chromatography-tandem mass spectrometry for quantification of lacosamide, an antiepileptic drug, in rat plasma and its application to pharmacokinetic study. Biomed Chromatogr. DOI: 10.1002/bmc.1668 (2011) (Epub ahead of print).
6. US FDA, US Department for Health and Human Services. Guidance for Industry: Bioanalytical method validation (2001).
7. Shah VP, Midha KK, Findlay JWA et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm Res. 17(12), 1551-1557 (2000).
8. Viswanathan CT, Bansal S, Booth B et al. Workshop/conference report - quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E42 (2007).
9. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin. Chem. 30(2), 290-292 (1984).
10. Bookbinder MJ, Panosian KJ. Correct and incorrect estimation of within-day and between-day variation. Clin. Chem. 32(9), 1734-1737 (1986).
11. Fast DM, Kelley M, Viswanathan CT et al. Workshop report and follow-up - AAPS Workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples - implications of crystal ity recommendations. AAPS J. 11(2), 238-241 (2009).